Quidel Stock Forecast, Price & News

Quidel's stock was trading at $89.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, QDEL shares have increased by 86.6% and is now trading at $167.37.
View which stocks have been most impacted by COVID-19.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Quidel.

Wall Street analysts have given Quidel a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Quidel wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Quidel is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021.
View our earnings forecast for Quidel.

Quidel Co. (NASDAQ:QDEL) issued its quarterly earnings data on Thursday, October, 29th. The company reported $5.78 earnings per share for the quarter, topping analysts' consensus estimates of $4.31 by $1.47. The company had revenue of $476.10 million for the quarter, compared to the consensus estimate of $445.30 million. Quidel had a net margin of 23.61% and a return on equity of 33.86%. Quidel's quarterly revenue was up 276.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.70 EPS.
View Quidel's earnings history.

Quidel updated its third quarter 2020 Pre-Market earnings guidance on Thursday, October, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $475-477 million, compared to the consensus revenue estimate of $394.28 million.

5 analysts have issued 1 year price targets for Quidel's stock. Their forecasts range from $90.00 to $363.00. On average, they expect Quidel's share price to reach $219.00 in the next year. This suggests a possible upside of 30.8% from the stock's current price.
View analysts' price targets for Quidel.

Some companies that are related to Quidel include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), Neogen (NEOG), ICU Medical (ICUI), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Atrion (ATRI), Cerus (CERS), OraSure Technologies (OSUR), Meridian Bioscience (VIVO), Anika Therapeutics (ANIK) and Antares Pharma (ATRS).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Square (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Quidel's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.11%), State Street Corp (2.16%), ArrowMark Colorado Holdings LLC (2.01%), Cannell Peter B & Co. Inc. (1.09%), Arrowstreet Capital Limited Partnership (1.03%) and New York State Common Retirement Fund (0.92%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Edward L Michael, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll.
View institutional ownership trends for Quidel.

QDEL stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, BlackRock Inc., New York State Common Retirement Fund, Paloma Partners Management Co, Cannell Peter B & Co. Inc., Massachusetts Financial Services Co. MA, Gabelli Funds LLC, and Gamco Investors INC. ET AL. Company insiders that have sold Quidel company stock in the last year include Edward Keith Russell, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, and Werner Kroll.
View insider buying and selling activity for Quidel.

QDEL stock was bought by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Thrivent Financial for Lutherans, Blair William & Co. IL, C WorldWide Group Holding A S, Point72 Asset Management L.P., AXA S.A., GW&K Investment Management LLC, and First Trust Advisors LP. Company insiders that have bought Quidel stock in the last two years include Douglas C Bryant, Edward L Michael, and Matthew Strobeck.
View insider buying and selling activity for Quidel.

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of QDEL stock can currently be purchased for approximately $167.37.

Quidel has a market capitalization of $7.04 billion and generates $534.89 million in revenue each year. The company earns $72.92 million in net income (profit) each year or $2.73 on an earnings per share basis. Quidel employs 1,250 workers across the globe.

The official website for Quidel is www.quidel.com.

Quidel's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The company can be reached via phone at 858-552-1100 or via email at [email protected]